News
Videos
Conferences
Events
Resources
Subscribe

|Videos|March 29, 2016

Top Tips to Patients

Episodes in this series

EP. 1 Common Oral Complications of MM Therapy

EP. 1 Common Oral Complications of MM Therapy

EP. 2 Mucositis: What to Know

EP. 2 Mucositis: What to Know

EP. 3 Osteonecrosis of the Jaw and Multiple Myeloma

EP. 3 Osteonecrosis of the Jaw and Multiple Myeloma

EP. 4 Top Tips to Patients

EP. 4 Top Tips to Patients

Newsletter

Stay up to date on cancer updates, research and education

Related Content

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

January 27th 2026

As patients with advanced cancer near the end of life, reducing unnecessary medications may help prioritize comfort, quality of life, and symptom relief: © stock.adobe.com

Rethinking Medications at the End of Life for Patients With Advanced Cancer

January 27th 2026

FDA

FDA Fast Tracks IBI3003 For Relapsed/Refractory Myeloma

January 27th 2026

Dr. Surbhi Sidana

How Tecvayli With Darzalex Works to Treat Multiple Myeloma

ByDr. Surbhi Sidana

January 19th 2026

Dr. Surbhi Sidana

Tecvayli With Darzalex Could Be ‘Truly Transformative’ in Multiple Myeloma

January 16th 2026

Trending on CURE

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

FDA Fast Tracks IBI3003 For Relapsed/Refractory Myeloma

Two-Time Breast Cancer Survivor Shares Advice for Fellow Patients

FDA Grants Designation to Bezuclastinib Combo in Advanced GIST

Cancer and Answering the Phone